Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of tropicamide 0.5% drop size on pupil dilation
2012-005219-18Phase 4Active
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tropicamide in Pupil anomaly (2 arms), sponsored by Elisabeth-TweeSteden Ziekenhuis. Primary endpoint: Primary: Within-subject pupil dilation at 40 minutes. Started Dec 2012; status: active.
02
Drugs
tropicamide
03
Conditions
Pupil anomaly
Beyond the preview
Go deeper on 2012-005219-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005219-18.